Industry

DUBLIN–(BUSINESS WIRE)–The “China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The Chinese TAVR market is expected to reach US$1,669.14 million in 2026, growing at a CAGR of 55.50%, for the duration spanning 2022-2026. While, the TMV market in China is forecasted to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Leadership Quadrant of Medical Battery Suppliers – 2022” report has been added to ResearchAndMarkets.com’s offering. The medical battery manufacture landscape is diverse and continually evolving. Major players in medical battery market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the medical battery market extends beyond … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insight on clinical and non-clinical factors that are driving the global CFTR Modulators market and its impact on the global pharmaceutical market landscape. The approval of the first CF transmembrane … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A/S, Provider of Competent Bioscience products to … [Read more…]

– Crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer’s disease – – For more than a decade Genentech has been working in collaboration with Banner Alzheimer’s Institute, the University of Antioquia in Colombia and the National Institute on Aging on this pioneering prevention study … [Read more…]

– Exelixis positioned to expand its biotherapeutics development pipeline through selection of antibody candidates directed to targets identified using BioInvent’s proprietary immuno-oncology (IO) screening platform and antibody library – ALAMEDA, Calif. & LUND, Sweden–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV) today announced that the companies have entered into an … [Read more…]

KWUN TONG, Hong Kong–(BUSINESS WIRE)–We are all aware of the importance of fitness activity. Many of us would like to participate, but we have a number of reservations. It seems difficult for workers to maintain a healthy work-life balance condition. However, practically everyone is attempting to find the time to do so. Working hours in … [Read more…]

Visit a Healthcare Provider in the Year 2050 with MedWand’s Special, One Day Pop-up Interactive, “The Doctor is In (Space)!” RANCHO SANTA MARGARITA, Calif. & WASHINGTON–(BUSINESS WIRE)–Taking off to the future of healthcare and beyond, MedWand™ Solutions is pleased to announce that the award-winning telehealth device company will partner with the FUTURES exhibition at the … [Read more…]

PARIS–(BUSINESS WIRE)–Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics announced, today that it has entered a new research collaboration with Sanofi. This new agreement is a follow-up to a Research Collaboration initiated at the end 2020 by Sanofi to bring the unique technologies of Aqemia to the design and discovery of novel … [Read more…]

SOLON, Ohio–(BUSINESS WIRE)–Energy Focus, Inc. (NASDAQ:EFOI) (“Energy Focus” or the “Company”), a leader in sustainable, energy-efficient lighting and controls systems and ultraviolet-c light disinfection products for the commercial, military maritime and consumer markets, today announced that the Company’s reconvened Annual Meeting of Stockholders (the “Annual Meeting”) scheduled for Wednesday, June 15, 2022 at 9:00 a.m. … [Read more…]